Global Heart Valve Repair and Replacement Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Heart Valve Repair and Replacement Market Research Report 2024
Heart valve is a thin flap of tissue, which ensures the unidirectional flow of blood throughout the cardiac cycle. Tricuspid valve, mitral valve, aortic valve, and pulmonary valve are the primary four valves in the heart. Valvular stenosis, atresia, valvular inadequacy or regurgitation, and prolapse are some major diseases associated with heart valve. These diseases are treated with the help of repair or replacement of the heart valve.
According to MRAResearch’s new survey, global Heart Valve Repair and Replacement market is projected to reach US$ 1419.4 million in 2033, increasing from US$ 1157.5 million in 2022, with the CAGR of 3.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Heart Valve Repair and Replacement market research.
Key companies engaged in the Heart Valve Repair and Replacement industry include Edwards LifeSciences, Medtronic, Boston Scientific, Abbott Laboratories, Abbott, JenaValve Technology, SYMETIS and Braile Biomedica, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Heart Valve Repair and Replacement were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Heart Valve Repair and Replacement market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Heart Valve Repair and Replacement market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Edwards LifeSciences
Medtronic
Boston Scientific
Abbott Laboratories
Abbott
JenaValve Technology
SYMETIS
Braile Biomedica
Segment by Type
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Valve Repair (TMVR)
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Heart Valve Repair and Replacement report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Heart Valve Repair and Replacement market is projected to reach US$ 1419.4 million in 2033, increasing from US$ 1157.5 million in 2022, with the CAGR of 3.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Heart Valve Repair and Replacement market research.
Key companies engaged in the Heart Valve Repair and Replacement industry include Edwards LifeSciences, Medtronic, Boston Scientific, Abbott Laboratories, Abbott, JenaValve Technology, SYMETIS and Braile Biomedica, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Heart Valve Repair and Replacement were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Heart Valve Repair and Replacement market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Heart Valve Repair and Replacement market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Edwards LifeSciences
Medtronic
Boston Scientific
Abbott Laboratories
Abbott
JenaValve Technology
SYMETIS
Braile Biomedica
Segment by Type
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Valve Repair (TMVR)
Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Heart Valve Repair and Replacement report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices